These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7937663)

  • 1. [Pathogenetic therapy of pulmonary tuberculosis in adolescents].
    Pavlova MV
    Probl Tuberk; 1994; (3):19-21. PubMed ID: 7937663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative effectiveness of etiopathogenetic therapy in adolescents with destructive pulmonary tuberculosis].
    Pavlova MV; Ivanova lA; Titarenko OT; Perova TL
    Probl Tuberk; 1994; (2):45-6. PubMed ID: 8036221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of different regimes of etiopathogenetic therapy in pulmonary tuberculosis in adolescents].
    Pavlova MV
    Probl Tuberk; 1995; (5):30-2. PubMed ID: 7567888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of drug resistance of Mycobacterium tuberculosis by methods of proportions and absolute concentrations].
    Golyshevskaia VI; Sevast'ianova EV; Voronina GA
    Probl Tuberk; 2001; (3):51-3. PubMed ID: 11508236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical aspects and outcome of recurrent pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Zyrianova TV; Naryshkina SL
    Probl Tuberk; 1993; (5):14-6. PubMed ID: 8295875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
    Shaĭkhaev AIa; Naumov VN
    Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antioxidants in the combined therapy of patients with chronic destructive pulmonary tuberculosis].
    Ivanova LA; Pavlova MV; Archakova LI
    Ter Arkh; 1994; 66(11):54-6. PubMed ID: 7900021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical course and effectiveness of treatment of destructive pulmonary tuberculosis in adolescents].
    Firsova VA; Nadyrshina RSh; Melikova VM
    Probl Tuberk; 1986; (5):14-7. PubMed ID: 3737587
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse effects of multi-drug therapy in patients with tuberculosis and ways of their correction].
    Gel'berg IS; Vol'f SB; Vrublevskaia NI; Pigalkova EN; Krotkova EN; Shevchuk DV; Avlasenko VS
    Probl Tuberk; 2002; (4):12-6. PubMed ID: 12125243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.